AMPARs are internalized after exposure to AMPA. (A) Living cells were labeled for surface AMPARs before treatment. After agonist application, surface receptors were detected with secondary antibodies on nonpermeabilized cells. Cells were then permeabilized, and internalized receptors were detected by using a secondary antibody with a different fluorescent conjugate. In an untreated cell (Left), AMPARs were primarily at the cell surface (green) with minimal internalized receptor immunoreactivity (red). Exposure to 100 μM AMPA for 15 min (Right) caused a dramatic increase in the amount of internalized AMPARs (red) along with a concomitant reduction in the amount of surface AMPAR staining (green). (B) Antibody-bound AMPARs internalized from the surface during agonist treatment are visualized exclusively by acid stripping antibodies from remaining surface AMPARs. In untreated, unstripped cells (Left), surface AMPARs were visualized in numerous puncta. After acid stripping of untreated cells (Center), labeling of surface AMPARs was almost abolished. After exposure of cells to 100 μM AMPA for 15 min, prominent staining of intracellular AMPAR puncta was apparent (Right), reflecting internalization of antibody-labeled AMPARs. (C) Quantitation of the acid-stripping assay in multiple specimens. Ordinate is mean number of internalized (acid-resistant) AMPAR puncta visualized per 10 μM dendrite for untreated cells (control), AMPA-treated cells (AMPA), and cells incubated for 15 min in the presence of 100 μM AMPA + 50 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).